NCT07527624

Brief Summary

Rare diseases are often synonymous with difficulties for sufferers, whether physical, mental or social. Patients suffering from rare diseases face specific problems, such as the long wait for a diagnosis, the geographical distance between the rare disease reference center and home, and the isolation created by this very disabling disease... Children suffering from rare genetic diseases have difficulty accessing higher education, but above all in finding an internship or work-study placement, due to the rarity of their disability. The aim of this study, entitled "Imagine La Suite", is to assess the difficulties encountered by young people with rare genetic diseases and disabilities in their search for vocational and university training or employment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
3mo left

Started Jan 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Jan 2024Aug 2026

Study Start

First participant enrolled

January 8, 2024

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

April 7, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 14, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 8, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 8, 2026

Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

2.4 years

First QC Date

April 7, 2026

Last Update Submit

April 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Entry into a training program, validation of a diploma, obtaining a 1st stable job

    18 Months

Secondary Outcomes (3)

  • Characterize the pathology components of the care pathway, barriers/ strengths to inclusion

    18 Months

  • Use of tools to facilitate socio-professional inclusion

    18 Months

  • Number of HR company representatives made aware of rare diseases

    18 Months

Interventions

surveyOTHER

Patients take part in a survey, completing a form in less than 30 minutes

Eligibility Criteria

Age15 Years - 25 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients currently aged 15-25 born between 1997 and 2007 and followed at Necker in the networks of the following disease reference centers: * epilepsy without deficiency ; * genodermatosis ; * constitutional bone diseases ; * craniofacial malformations; * deafness;

You may qualify if:

  • Current age 15-25 years born between 1997 and 2007
  • Rare genetic disease confirmed by a genetic test, originating in childhood and followed at Necker in the networks of the following disease reference centers:
  • epilepsy without deficiency ;
  • genodermatosis ;
  • constitutional bone diseases ;
  • craniofacial malformations;
  • deafness;

You may not qualify if:

  • Patient or parent's opposition to study participation
  • Patient with intellectual disability (IQ \< 70)
  • Patients with pathologies involving intellectual disability and patients with a clinical sign of intellectual disability.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imagine Clinical Research

Paris, Île-de-France Region, 75015, France

RECRUITING

MeSH Terms

Conditions

Rare Diseases

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Fatima clinical project manager, Medical doctor

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2026

First Posted

April 14, 2026

Study Start

January 8, 2024

Primary Completion (Estimated)

June 8, 2026

Study Completion (Estimated)

August 8, 2026

Last Updated

April 14, 2026

Record last verified: 2026-04

Locations